UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KLRS holding history

Kalaris Therapeutics, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KLRS overview All 13F holders of KLRS Full Q4 2025 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of KLRS by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−230,000−100.0%	Sold out	Holders
Q3 2023	230,000	$494.5K	<0.1%	+60,000+35.3%	Added	Holders
Q2 2023	170,000	$578.0K	<0.1%	+170,000	New	Holders